generic glp-1 receptor agonists Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care Wegovy, Zepbound, Ozempic — GLP-1
Description
Accessing Treatment Through the NHS Maridebart cafraglutide is not currently available through the NHS as it has not yet received marketing authorisation from the MHRA or the European Commission (following EMA assessment)
Another approved use for Victoza is to reduce the risk of major cardiovascular disease, like heart attack or stroke, in adults with type 2 diabetes with known heart disease
The New England Journal of Medicine, 388(11), 961963
Pharmacologic glycemic management of type 2 diabetes in adults 2024 update
